NEW YORK, November 11, 2016 /PRNewswire/ --
Stock-Callers.com has initiated coverage on the following Personal Products equities: Coty Inc. (NYSE: COTY), The Estee Lauder Cos. Inc. (NYSE: EL), Unilever N.V. (NYSE: UN), and Kimberly-Clark Corp. (NYSE: KMB). According to a report released by Research and Markets earlier this month, the global personal care specialty ingredients market is forecasted to reach $15.76 billion by 2024, with active specialty ingredients accounting for 58.6% of the global revenue. Learn more about these stocks by accessing their free research reports at:
New York headquartered Coty Inc.'s shares saw a decline of 5.60% and finished Thursday's trading session at $18.55. A total volume of 16.36 million shares was traded, which was above their three months average volume of 12.61 million shares. The stock is trading below its 50-day moving average by 21.49%. Moreover, shares of Coty, which together with its subsidiaries, manufactures, markets, and distributes beauty products worldwide, have a Relative Strength Index (RSI) of 18.39.
On November 01st, 2016, research firm Morgan Stanley resumed its 'Equal-Weight' rating on the Company's stock.
On November 09th, 2016, Coty reported that net revenues of $1.08 billion in Q1 FY17 decreased 3% as reported and decreased 2% at a constant currency from Q1 FY16. Gross margin of 58.8% in the reported quarter decreased from 60.1% in Q1 FY16 and adjusted gross margin of 58.8% fell from 60.3% in Q1 FY16, reflecting the addition of the lower gross margin Brazil acquisition. Net income decreased from $125.7 million in Q1 FY16, reflecting lower operating income and higher tax expenses. Free research report on COTY is available at:
On Thursday, shares in New York-based The Estee Lauder Cos. Inc. recorded a trading volume of 2.85 million shares, which was higher than their three months average volume of 1.83 million shares. The stock ended the session 2.71% lower at $78.21. The Company's shares are trading 9.93% below their 50-day moving average. Furthermore, shares of Estee Lauder, which manufactures and markets skin care, makeup, fragrance, and hair care products worldwide, have an RSI of 25.08.
On October 24th, 2016, research firm Stifel reiterated its 'Buy' rating on the Company's stock with a decrease of the target price from $104 a share to $99 a share.
On November 02nd, 2016, Estee Lauder reported that its Q1 FY17 net sales increased 1% to $2.87 billion from $2.83 billion in Q1 FY16. The company reported that its net income in the reported quarter came in at $294 million from $309 million in Q1 FY16. The complimentary research report on EL can be downloaded at:
Shares in Rotterdam, the Netherlands-based Unilever N.V. closed the day at $39.95, down 3.76% from the previous trading session. The stock recorded a trading volume of 4.88 million shares, which was above its three months average volume of 1.89 million shares. The Company's shares are trading 9.32% below their 200-day moving average. Additionally, shares of Unilever, which operates in the fast-moving consumer goods market worldwide, have an RSI of 26.76.
On November 01st, 2016, Convoy announced that it has partnered with Unilever North America, a leader in supply chain management, in a multi-year trucking agreement to help advance Unilever's operations, improve the lives of drivers, and ultimately help to reduce the environmental impact of trucking. Convoy will allow Unilever North America to maximize each shipment by leveraging high-quality, local trucking resources to reduce the amount of empty miles driven while enhancing the livelihoods of drivers. Visit us today and access our complete research report on UN at:
At the closing bell yesterday, shares in Dallas, Texas headquartered Kimberly-Clark Corp. ended 2.79% lower at $112.15. A total volume of 2.99 million shares was traded, which was above their three months average volume of 1.71 million shares. The stock is trading below its 50-day moving average by 7.45%. Furthermore, shares of Kimberly-Clark, which together with its subsidiaries, manufactures and markets personal care, consumer tissue, and professional products worldwide, have an RSI of 32.99.
On October 24th, 2016, Kimberly-Clark reported that net sales of $4.6 billion for Q3 2016 decreased approximately 3% compared to Q3 2015. The company's diluted net income per share for Q3 2016 came in at $1.52 as compared to earnings of $1.41 in Q3 2015.
On October 26th, 2016, research firm CLSA downgraded the Company's stock rating from 'Outperform' to 'Underperform'. Get free access to your research report on KMB at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA